Turner Investments’s Emergent Biosolutions EBS Stock Holding History

Turner Investments’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-37,620	Closed	-$1.37M	–	213
2016 Q1	$1.37M	Sell	37,620 -27,600	-42%	-$975K	0.37%	92
2015 Q4	$2.61M	Hold	65,220	–	–	0.54%	67
2015 Q3	$1.86M	Hold	65,220	–	–	0.38%	93
2015 Q2	$2.15M	Sell	65,220 -6,660	-9%	-$206K	0.39%	83
2015 Q1	$2.07M	Sell	71,880 -27,200	-27%	-$780K	0.37%	92
2014 Q4	$2.7M	Buy	99,080 +62,350	+170%	+$1.49M	0.32%	89
2014 Q3	$783K	Buy	36,730 +17,820	+94%	+$408K	0.05%	370
2014 Q2	$425K	Buy	+18,910	New	+$440K	0.02%	432

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Turner Investments's EBS Position: Q2 2016 in Review

Turner Investments sold out of Emergent Biosolutions (EBS) in Q2 2016, closing a stake of 37,620 shares — an estimated $1.37M sold.

Turner Investments first reported a position in EBS in Q2 2014 and held it in 8 quarters. The position peaked at $2.7M in Q4 2014. 224 funds tracked by Wall St. Rank hold EBS as of Q2 2016.

Turner Investments reported no remaining Emergent Biosolutions position as of Q2 2016 after selling out during the quarter.
Turner Investments sold 37,620 Emergent Biosolutions shares in Q2 2016, an estimated $1.37M.
Turner Investments first reported a position in Emergent Biosolutions in Q2 2014 and held it in 8 quarters.
Turner Investments's Emergent Biosolutions position peaked at $2.7M in Q4 2014.
224 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2016.

Based on Turner Investments's 13F filing for Q2 2016, filed 5 Aug 2016.